Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$729M |
| 2 |
Booking.com
BKNG
|
+$309M |
| 3 |
PepsiCo
PEP
|
+$294M |
| 4 |
Comcast
CMCSA
|
+$285M |
| 5 |
Netflix
NFLX
|
+$242M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$778M |
| 2 |
Walmart Inc
WMT
|
+$382M |
| 3 |
GE Aerospace
GE
|
+$361M |
| 4 |
NetEase
NTES
|
+$344M |
| 5 |
Becton Dickinson
BDX
|
+$343M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.65% |
| 2 | Technology | 14.45% |
| 3 | Consumer Discretionary | 11.36% |
| 4 | Financials | 11.34% |
| 5 | Industrials | 8.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WSR
2651
DELISTED
Whitestone REIT
WSR
| $1.02M | ﹤0.01% |
98,400
+60,700
| +161% | +$741K |
|
|
GENE
2652
DELISTED
Genetic Technologies Ltd.
GENE
| $1.02M | ﹤0.01% |
49,149
-80
| -0.2% | -$2.31K |
|
|
RC
2653
Ready Capital
RC
$294M
| $1.02M | ﹤0.01% |
67,400
-125,900
| -65% | -$1.84M |
|
|
PRSS
2654
DELISTED
CafePress Inc.
PRSS
| $1.02M | ﹤0.01% |
755,500
+39,500
| +6% | +$61.8K |
|
|
SIFY
2655
Sify Technologies
SIFY
$1.14B
| $1.02M | ﹤0.01% |
82,250
+19,900
| +32% | +$251K |
|
|
HMSY
2656
DELISTED
HMS Holdings Corp.
HMSY
| $1.02M | ﹤0.01% |
60,312
-314,988
| -84% | -$5.28M |
|
|
CCLP
2657
DELISTED
CSI Compressco LP
CCLP
| $1.01M | ﹤0.01% |
139,784
-70,468
| -34% | -$487K |
|
|
CWAY
2658
DELISTED
Coastway Bancorp, Inc.
CWAY
| $1.01M | ﹤0.01% |
37,200
+8,302
| +29% | +$190K |
|
2659
Spyre Therapeutics
SYRE
$8.98B
| $1.01M | ﹤0.01% |
4,080
+2,796
| +218% | +$505K |
|
2660
Cineverse
CNVS
$68.2M
| $1.01M | ﹤0.01% |
36,707
+1,930
| +6% | +$51.7K |
|
2661
Kimco Realty
KIM
$16.4B
| $999K | ﹤0.01% |
+69,400
| New | +$1.07M |
|
|
CIVI
2662
DELISTED
Civitas Resources
CIVI
| $998K | ﹤0.01% |
+36,000
| New | +$991K |
|
2663
Ocugen
OCGN
$458M
| $996K | ﹤0.01% |
6,037
+1,995
| +49% | +$318K |
|
2664
Atkore
ATKR
$3.17B
| $994K | ﹤0.01% |
+50,100
| New | +$1.08M |
|
|
BRS
2665
DELISTED
Bristow Group, Inc.
BRS
| $989K | ﹤0.01% |
+76,100
| New | +$1.13M |
|
|
CVGW
2666
DELISTED
Calavo Growers
CVGW
| $987K | ﹤0.01% |
10,700
-13,420
| -56% | -$1.17M |
|
2667
Apyx Medical
APYX
$126M
| $984K | ﹤0.01% |
331,400
-4,800
| -1% | -$12.4K |
|
|
SAUC
2668
DELISTED
Diversified Restaurant Holdings, Inc. Common stock
SAUC
| $978K | ﹤0.01% |
724,700
-4,000
| -0.5% | -$6.14K |
|
2669
Theravance Biopharma
TBPH
$878M
| $977K | ﹤0.01% |
+40,300
| New | +$1.11M |
|
2670
Vanguard Long-Term Corporate Bond ETF
VCLT
$8.8B
| $975K | ﹤0.01% |
+10,668
| New | +$982K |
|
2671
Amphastar Pharmaceuticals
AMPH
$858M
| $968K | ﹤0.01% |
51,600
+39,800
| +337% | +$748K |
|
|
PIR
2672
DELISTED
Pier 1 Imports, Inc.
PIR
| $968K | ﹤0.01% |
15,030
-4,105
| -21% | -$279K |
|
|
EBTC
2673
DELISTED
Enterprise Bancorp
EBTC
| $967K | ﹤0.01% |
27,400
-648
| -2% | -$21.8K |
|
|
EMMS
2674
DELISTED
Emmis Communications Corp
EMMS
| $967K | ﹤0.01% |
223,201
-9,788
| -4% | -$34.4K |
|
2675
DLH Holdings
DLHC
$67.8M
| $965K | ﹤0.01% |
165,183
+3,893
| +2% | +$23.1K |
|
Similar funds
Jim Simons's Q1 2018 Portfolio in Review
As of Q1 2018, Jim Simons held 3,782 positions worth $91.4B, up 0.81% from $90.7B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Jim Simons's Q1 2018 filing shows 474 new, 1,645 increased, 1,192 reduced and 438 closed positions. Its largest new stake was Amazon: 10,199,100 shares worth $738M. The largest sale was ExxonMobil, an estimated $778M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q1 2018 buy was Amazon: 10,199,100 shares worth $738M.
- Jim Simons added most to Booking.com in Q1 2018, an estimated $309M increase.
- Jim Simons's biggest Q1 2018 reduction was ExxonMobil, cutting an estimated $778M.
- Jim Simons fully exited Marathon Petroleum in Q1 2018, selling an estimated $132M.
- Jim Simons's ten largest holdings make up 9% of its $91.4B portfolio in Q1 2018.
- Jim Simons opened 474 new positions and closed 438 in Q1 2018.
- Jim Simons's portfolio value rose 0.81% quarter-over-quarter to $91.4B.
Based on Renaissance Technologies's 13F filing for Q1 2018, filed 14 May 2018.